These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 28529048

  • 1. Laboratory-based performance evaluation of PIMA CD4+ T-lymphocyte count point-of-care by lay-counselors in Kenya.
    Zeh C, Rose CE, Inzaule S, Desai MA, Otieno F, Humwa F, Akoth B, Omolo P, Chen RT, Kebede Y, Samandari T.
    J Immunol Methods; 2017 Sep; 448():44-50. PubMed ID: 28529048
    [Abstract] [Full Text] [Related]

  • 2. A meta-analysis of the performance of the Pima™ CD4 for point of care testing.
    Scott LE, Campbell J, Westerman L, Kestens L, Vojnov L, Kohastsu L, Nkengasong J, Peter T, Stevens W.
    BMC Med; 2015 Jul 25; 13():168. PubMed ID: 26208867
    [Abstract] [Full Text] [Related]

  • 3. Task-shifting of CD4 T cell count monitoring by the touchscreen-based Muse™ Auto CD4/CD4% single-platform system for CD4 T cell numeration: Implication for decentralization in resource-constrained settings.
    Kouabosso A, Mossoro-Kpinde CD, Bouassa RM, Longo JD, Mbeko Simaleko M, Grésenguet G, Bélec L.
    J Immunol Methods; 2018 Apr 25; 455():95-98. PubMed ID: 29402397
    [Abstract] [Full Text] [Related]

  • 4. Evaluation of the FACSPresto, a New Point of Care Device for the Enumeration of CD4% and Absolute CD4+ T Cell Counts in HIV Infection.
    Makadzange AT, Bogezi C, Boyd K, Gumbo A, Mukura D, Matubu A, Ndhlovu CE.
    PLoS One; 2016 Apr 25; 11(7):e0157546. PubMed ID: 27388763
    [Abstract] [Full Text] [Related]

  • 5. Performance of point-of-care CD4 testing technologies in resource-constrained settings: a systematic review and meta-analysis.
    Pham MD, Agius PA, Romero L, McGlynn P, Anderson D, Crowe SM, Luchters S.
    BMC Infect Dis; 2016 Oct 21; 16(1):592. PubMed ID: 27769181
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Performance Evaluation of the Becton Dickinson FACSPresto™ Near-Patient CD4 Instrument in a Laboratory and Typical Field Clinic Setting in South Africa.
    Coetzee LM, Moodley K, Glencross DK.
    PLoS One; 2016 Oct 21; 11(5):e0156266. PubMed ID: 27224025
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Multisite evaluation of a point-of-care instrument for CD4(+) T-cell enumeration using venous and finger-prick blood: the PIMA CD4.
    Diaw PA, Daneau G, Coly AA, Ndiaye BP, Wade D, Camara M, Mboup S, Kestens L, Dieye TN.
    J Acquir Immune Defic Syndr; 2011 Dec 01; 58(4):e103-11. PubMed ID: 21909029
    [Abstract] [Full Text] [Related]

  • 12. Performance of the BD FACSPresto near to patient analyzer in comparison with representative conventional CD4 instruments in Cameroon.
    Sagnia B, Mbakop Ghomsi F, Gutierrez A, Sosso S, Kamgaing R, Nanfack AJ, Nji N, Ambada G, Lissom A, Tchouangueu TF, Ngu Ndengkoh L, Domkam I, Nchinda G, Ndjolo A.
    AIDS Res Ther; 2020 Aug 17; 17(1):53. PubMed ID: 32799909
    [Abstract] [Full Text] [Related]

  • 13. Performance evaluation of the MBio Diagnostics point-of-care CD4 counter.
    Logan C, Givens M, Ives JT, Delaney M, Lochhead MJ, Schooley RT, Benson CA.
    J Immunol Methods; 2013 Jan 31; 387(1-2):107-13. PubMed ID: 23063690
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Comparison of point-of-care versus laboratory-based CD4 cell enumeration in HIV-positive pregnant women.
    Myer L, Daskilewicz K, McIntyre J, Bekker LG.
    J Int AIDS Soc; 2013 Sep 16; 16(1):18649. PubMed ID: 24044627
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of PIMA™® point of care technology for CD4 T cell enumeration in Kenya.
    Mwau M, Adungo F, Kadima S, Njagi E, Kirwaye C, Abubakr NS, Okubi LA, Waihenya M, Lusike J, Hungu J.
    PLoS One; 2013 Sep 16; 8(6):e67612. PubMed ID: 23825674
    [Abstract] [Full Text] [Related]

  • 18. Field evaluation of PIMA point-of-care CD4 testing in Rakai, Uganda.
    Galiwango RM, Lubyayi L, Musoke R, Kalibbala S, Buwembo M, Kasule J, Serwadda D, Gray RH, Reynolds SJ, Chang LW.
    PLoS One; 2014 Sep 16; 9(3):e88928. PubMed ID: 24614083
    [Abstract] [Full Text] [Related]

  • 19. Performance Evaluation of the MyT4 Technology for Determining ART Eligibility.
    Sitoe N, Macamo R, Meggi B, Tobaiwa O, Loquiha O, Bollinger T, Vojnov L, Jani I.
    PLoS One; 2016 Sep 16; 11(10):e0165163. PubMed ID: 27780216
    [Abstract] [Full Text] [Related]

  • 20. Point-of-care CD4+ technology implementation in Free State, South Africa, was associated with improved patient health outcomes.
    Van Turha L, Maharaj K, Rose A, Boeke C, Peter TF, Vojnov L, Quevedo J, Tsibolane Y.
    S Afr Med J; 2020 Jan 29; 110(2):126-131. PubMed ID: 32657683
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.